Form 4 for TELA TELA Bio, Inc.
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001062993-23-005025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-27 | 2023-02-24 | TELA | KOBLISH ANTONY | CEO | F - Tax | $11.03 | -6,034 | 293.0K | -2% | -$66.6K |
| D | 2023-02-27 | 2023-02-23 | TELA | KOBLISH ANTONY | CEO | A - Grant | $0.00 | +61.2K | 299.1K | +26% | $0 |
| D | 2023-02-27 | 2023-02-23 | TELA | KOBLISH ANTONY | CEO | A - Grant | $0.00 | +96.1K | 96.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-24 | F | D | 6,034 | $11.03 | 293,019 | D | — | — | (F2) Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs. |
| 2 | Common | Common Stock | 2023-02-23 | A | A | 61,200 | $0.00 | 299,053 | D | — | — | (F1) These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2024, subject to the Reporting Person's continuous service through the applicable vesting dates. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-02-23 | A | A | 96,100 | $0.00 | 96,100 | D | $10.50 · — to 2033-02-23 | 96,100 Common Stock | (F3) The option vests 25% on February 23, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates. |